$249.00
AMI’s Specialty HUB Services Providers 2023-2024 report includes profiles of approximately 70 companies that provide a wide range of specialty pharmaceutical hub and patient support services.
Company profiles include: background, strategy, key decision-makers, financial/investor information, products and services, and recent activities.
The report is available for $249 for a single-user license. Department and Corporate Licenses are available, please click here.
AMI’s Specialty HUB Services Providers 2023-2024 report includes profiles of approximately 70 companies that provide a wide range of specialty pharmaceutical hub and patient support services.
Specialty hub services act as a single point of contact for patients and work to make the patient’s journey easier, providing assistance with onboarding, affordability, delivery and tracking, adherence, and data reporting. Hub services vary depending on the needs of the patient.
Due to the complexity and the range of product and service offerings, the number of companies offering one or a number of hub and patient support services continues to increase in this highly competitive market.
As the market for digital health applications continue to grow, patients are rapidly embracing a variety of tools to take control of their health and better manage their chronic disease. New market entrants are introducing technology-based solutions focusing on a category called specialty-lite drugs in an attempt to gain a foothold in the market.
As the leading source for market intelligence on hub service providers, AMI offers custom research that addresses the markets’ needs, preferences and expectations, and designs projects and delivers results that helps you understand how to address the opportunity.
Company profiles include: background, strategy, key decision-makers, financial/investor information, products and services, and recent activities.
The report is available for $249 for a single-user license. Department and Corporate Licenses are available, please click here.
Table of Contents
Executive Summary – pgs. 5-7
Company Profiles
BioPharmacy/Specialty
Specialty Pharmacy Database – November 2023 Monthly Snapshot
BioPharmacy/Specialty
Market Access & Distribution
Market Access & Distribution